Apolipoprotein E polymorphism in patients with neuropsychiatric SLE

Clinical Rheumatology

Volumn 23, Issue 2, 2004, Pages 97-101

  Pullmann Jr , Rudolf ^a   Ŝkeren̂ová, Maria ^a   Hybenová, Jana ^a   Lukáĉ, Jozef ^b   Rovenský, Jozef ^b   Pullmann, Rudolf ^a  

^a MARTIN FACULTY HOSPITAL   (Slovakia)

^b NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

Author keywords

Apolipoprotein E; Neuropsychiatric SLE; Polymorphism

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; FISHER EXACT TEST; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; ISOELECTRIC FOCUSING; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROBIOLOGY; NEUROLOGIC DISEASE; PERIPHERAL NEUROPATHY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RANK SUM TEST; RECURRENCE RISK; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 2342444606     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-003-0796-0     Document Type: Article

References (28)

1. Sibbitt WL, Jung RE, Brooks WM (1999) Neuropsychiatric systemic lupus erythematosus. Compr Ther 25:198-208
2. ACR ad hoc Committee on Neuropsychiatric Lupus Nomenclature (1999) the American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42:599-608
3. West SG (1996) Lupus and the central nervous system. Curr Opin Rheumatol 8:408-414
4. Horsburgh K, McCarron MO, White F, Nicoll JA (2000) The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models. Neurobiol Aging 21:245-255
5. Curtiss LK, Boisvert WA (2000) Apolipoprotein E and atherosclerosis. Curr Opin Lipidol 11:243-251
6. Mahley RW, Rall SC Jr (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1:507-537
7. Saunders AM, Strittmatter WJ, Schmechel D et al. (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472
8. Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT (1995) Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 38:254-259
9. Harrington CR, Roth M, Xuereb JH, McKenna PJ, Wischik CM (1995) Apolipoprotein E type epsilon 4 allele frequency is increased in patients with schizophrenia. Neurosci Lett. 202:101-104
10. Tan EM, Cohen AS, Fries JF et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
11. Denburg JA, Carbotte RM, Denburg SD (1987) Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology 37:464-467
12. Wallace DJ, Hahn BH (1997) Dubois' lupus erythematosus, 5th edn. Baltimore, Williams & Wilkins
13. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545-548
14. Hackler R, Schafer JR, Motzny S et al. (1994) Rapid determination of apolipoprotein E phenotypes from whole plasma by automated isoelectric focusing using PhastSystem and immunofixation. J Lipid Res 35:153-158
15. Moore PM (1997) Neuropsychiatric systemic lupus erythematosus. Stress, stroke, and seizures. Ann NY Acad Sci 823: 1-17
16. Karassa FB, Ioannidis JPA, Touloumi G, Boki KA, Moutsopoulos HM (2000) Risk factors for central nervous system involvement in systemic lupus erythematosus. QJ Med 93:169-174
17. Mok CC, Lau CS, Wong RW (2001) Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 28:766-771
18. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A (2001) The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57:496-500
19. Bedlack RS, Strittmatter WJ, Morgenlander JC (2000) Apolipoprotein E and neuromuscular disease. Apolipoprotein E and neuromuscular disease: a critical review of the literature. Arch Neurol 57:1561-1565
20. Gutman CR, Strittmatter WJ, Weisgraber KH, Matthew WD (1997) Apolipoprotein E binds to and potentiates the biological activity of ciliary neurotrophic factor. J Neurosci. 17:6114-6121
21. Huang DY, Weisgraber KH, Strittmatter WJ, Matthew WD (1995) Interaction of apolipoprotein E with laminin increases neuronal adhesion and alters neurite morphology. Exp Neurol 136:251-257
22. Volpe BT (1997) Delayed neuronal degeneration results from endogenous glutamate excess. Possible role in NPSLE. Ann NY Acad Sci 823:185-187
23. Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE (1999) Expression of human apolipoprotein E3 or E4 in the brains of Apoe -/- mice: isoform-specific effects on neurodegeneration. J Neurosci 19:4867-4880
24. McCarron MO, Delong D, Alberts MJ (1999) APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology 53:1308-1311
25. Pepe MG, Curtiss LK (1986) Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-ln. J Immunol 136:3716-3723
26. Kelly ME, Clay MA, Mistry MJ, Hsieh-Li HM, Harmony JAK (1994) Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity. Cell Immunol 159:124-139
27. Saunders AM (2000) Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses. J Neuropathol Exp Neurol 59:751-758
28. Marks V, Cantor T, Meško D, Pullmann R, Nosáľ ová G (2003) Differential Diagnosis by Laboratory Medicine. A Quick Reference for Physicians. Springer, Berlin Heidelberg New York